Navigation Links
Addrenex Pharmaceuticals Announces Licensing Agreement With Dream Pharma
Date:8/5/2009

RESEARCH TRIANGLE PARK, N.C., Aug. 5 /PRNewswire/ -- Addrenex Pharmaceuticals, a specialty pharmaceutical company dedicated to developing treatments to regulate the adrenergic system, announced today an exclusive partnership with Dream Pharma. In keeping with its long-range plan to advance the treatment of adrenergic-related conditions throughout the world, Addrenex has licensed the right to manufacture, market and sell its lead product, Clonicel, in Korea to Dream Pharma. Dream Pharma is a Division of the Hanwha Group, one of the top 10 business conglomerates in Korea.

Clonicel is being developed for both the treatment of hypertension and attention deficit hyperactivity disorder. Clonicel is a patented extended-release formulation of clonidine hydrochloride, a drug currently approved for hypertension.

"We are very excited to partner with Dream Pharma to bring this important treatment to children struggling with ADHD in Korea," said Steve Butts, Vice President, Commercial Operations at Addrenex Pharmaceuticals. "This agreement is another important milestone for Addrenex as we continue to expand our business activities globally."

This partnership agreement coincides with the 3rd anniversary of the founding of Addrenex. In just three short years, the company has signed several licensing deals with major pharmaceutical companies, advanced four products to various stages of clinical trials and acquired an extensive pipeline of compounds primed for future development. Moving forward, the company will continue to focus on developing treatments for the origin of a wide range of conditions regulated by the adrenergic system. These conditions range from menopausal flushing to insomnia to pain. Currently, these conditions are being managed symptomatically rather than addressing the root cause.

"It is exciting to see so much progress in such a short period of ti
'/>"/>

SOURCE Addrenex Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... Drugs commonly used to treat glaucoma may cause droopy ... vision, according to a new study. The drugs, ... reduce eye pressure, have already been shown to cause ... researchers said, suggesting that the new findings could lead ... be conservative when prescribing these drugs, the researchers added, ...
(Date:5/24/2013)... New York, New York (PRWEB) May 24, 2013 ... naturally white teeth. It is not uncommon for the majority ... natural teeth. Whether it is due to a coffee addiction ... this is why whitening procedures are so popular. ... of a new and very effective whitening system: Venus White ...
(Date:5/24/2013)... May 24, 2013 Area homeowners dreaming about ... new hot tubs to choose from at factory-direct pricing during ... The sales event takes place at Emerald Pool and ... , Jacuzzi, the industry's leading hot tub brand, scheduled ... the country. The event will feature popular hot tub models ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 The nation’s ... involving Intuitive Surgical Inc.’s da Vinci Surgical System concluded ... records, a Washington State Court jury ruled in a ... training a surgeon who performed a da Vinci prostatectomy ... The patient’s family had alleged in their lawsuit that ...
(Date:5/24/2013)... Two mutations central to the development of infantile myofibromatosis ... bone, and soft tissuemay provide new therapeutic targets, according ... Mount Sinai. The findings, published in the American ... treatment options for this debilitating disease, for which the ... the tumors. , IM is an inheritied disorder that ...
Breaking Medicine News(10 mins):Health News:Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds 2Health News:Herald Square Dental Introduces New In-office Whitening System: Venus White Max 2Health News:Truckload of Jacuzzi® Hot Tubs Rolls into Bend, Oregon on May 24, 2013 for Sales Event 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 3Health News:Researchers identify first drug targets in childhood genetic tumor disorder 2
... but are prepared to try and lessen the number of ... studying healthcare literature, a team of Cochrane Researchers could find ... of cutting down the number of cigarettes. ,The ... helping them to stop smoking completely. But, little thought has ...
... it doesnt come cheap. But the new bionic hand, developed by a ... , ,It can't click its fingers or play the ... ,It can, for instance, turn a key in a lock, hold ... , ,David Gow who works with with Lothian NHS in ...
... Researchers have revealed that combining a non-pyrethroid insecticide, ... to be an effective insecticide-repellent synergy against ... ,A combination of the two had proved ... addition of their respective properties. Mosquito nets soaked ...
... a 10 million dollar specialist cancer hospital which will enable ... . ,Mwanawasa said the National Cancer Diseases Hospital ... cancer patients in Zambia who have previously had to be ... average 10,000 dollars per person. ,"Treatment at the ...
... with the U.K.-based Oxford Brookes University, has opened a ... ,For the people of the city that subsist ... development. For now scientific testing methodology is generating enough ... which food is converted into blood glucose) to prompt ...
... the premier institute of medicine AIIMS and has been asked ... State Consumer Commission . ,All India Institute of Medical ... cancer patient and removing her breast as a part of ... by Justice J D Kapoor held the hospital guilty of ...
Cached Medicine News:Health News:Chain Smokers Prepared to Lessen Their Daily Cigs Rather Than Quitting 2Health News:Scottish Engineer Devises Versatile Hand 2Health News:Insecticide and Repellent Combo Effective in Eliminating Malarial Mosquitoes 2Health News:A Centre for Glycemic Index Testing Opened in Chennai 2Health News:AIIMS Fined Rs 5 Lakhs for Negligence 2
(Date:5/23/2013)... Corporation (NYSE: HAE ) announced today that ... present at The Deutsche Bank 38 th Annual dbAccess ... on May 29, 2013 at 1:30pm Eastern time.  ... may access Mr. Lindop,s presentation live via webcast at: ... (NYSE: HAE ) is a global healthcare company ...
(Date:5/23/2013)... KNOXVILLE, Tenn. , May 23, 2013 /PRNewswire/ ... of 24-hour nurse triage and nurse advice lines, ... 10-person committee, comprising physician, nursing and administrative leaders, ... providing safe, quality and cost-effective services for hospital ... "As our national healthcare system evolves, it,s imperative ...
(Date:5/23/2013)... Mich. , May 23, 2013  Every day, their ... of air to his lungs. April and Bryan ... dire predictions weren,t true. "Quite a few doctors ... hospital alive," says April Gionfriddo , about ... desperate. Anything that would work, we would take it and ...
Breaking Medicine Technology:TeamHealth Medical Call Center Forms Clinical Advisory Committee 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4
... 12, 2011 Southern Home Medical Equipment, Inc. ... healthcare professionals and equipment to medical institutions, announced ... operations for fiscal year 2010 have been restated ... Medical Staffing. In a previous announcement ...
... Inc., a privately held medical device company focused on ... announced the initial launch of its Durango™ Stand-Alone ALIF ... was made at the 2011 American Association of Neurological ... The Durango system is intended to treat degenerative disc ...
Cached Medicine Technology:Southern Home Medical Equipment Reports Additional Revenues and Profits for 2010 2Lanx®, Inc. Launches Durango™ Stand-Alone ALIF System 2
... is made of two probes which are ... sensor distance., ,VersaFlex disposable catheters for ... VersaFlex catheters are the smallest diameter esophageal ... are the perfect combination of flexibility and ...
... Slimline multi-use catheters are designed ... solution with the following benefits:, ... reference: ,In procedures where the multi-use ... Gel creates stable contact to the ...
FLEXILOG accessory....
FLEXILOG spare part....
Medicine Products: